United States Attorney David Metcalf has announced the filing of a superseding indictment against three Arizona residents, charging them with operating fraudulent medical clinics and prescribing unapproved drugs. The defendants, Mary Blakley and Fred Blakley, along with Janmarie Lanzo, are accused of conspiracy to commit mail and wire fraud, as well as conspiracy to violate the Food, Drug, and Cosmetic Act.
The indictment details that Mary Blakley, also known by several aliases including “Doctor Mary,” and Fred Blakley ran a clinic business offering “full body scans” using ultrasound machines. These scans were purportedly enhanced by a “smart chip technology” allegedly invented by Mary Blakley. Clients were charged approximately $300 for these scans across the United States.
Janmarie Lanzo is described as a business associate who participated in the clinics’ operations and sold products recommended by Mary Blakley based on scan results. The indictment claims that these scans falsely diagnosed various diseases, including cancer.
The defendants are also alleged to have promoted Aetheion cream for treating cancer and other conditions and sold fenbendazole, an antiparasitic veterinary product, for human cancer treatment. To disguise their activities, they reportedly claimed to be conducting research while distributing products under misleading regulatory pretenses. They used coded language and deceptive practices to conceal their operations.
Mary Blakley and Fred Blakley could face up to 165 years in prison if convicted; Janmarie Lanzo faces up to five years. The investigation was carried out by the FBI alongside the FDA’s Office of Criminal Investigations. Assistant United States Attorneys Ruth Mandelbaum and Paul G. Shapiro are prosecuting the case.
It is important to note that all charges are accusations at this stage, with each defendant presumed innocent until proven guilty in court.
